NCT02893410View on ClinicalTrials.gov

Drug Observance and Side Effects of Cytoreductive Drugs in PV and ET Patients

CompletedOBSERVATIONAL
Enrollment

286

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Polycythemia VeraEssential Thrombocythemia
Trial Locations (1)

29609

CHRU de Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT02893410 - Drug Observance and Side Effects of Cytoreductive Drugs in PV and ET Patients | Biotech Hunter | Biotech Hunter